From Minds to Machines: India’s top CEOs and CHROs chart the AI-Led talent blueprint at ET NexTech Human Capital Summit 2026
NEW DELHI, Feb. 25, 2026 /PRNewswire/ -- The Economic Times NexTech Human…
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
February 23, 2026 17:10 ET | Source: Kyntra Bio FG-3246 and enzalutamide…
Not sure how to give wishes for the Year of the Horse? Let’s hear from CGs in Guangzhou
GUANGZHOU, China, Feb. 20, 2026 /PRNewswire/ -- A news report from South:…
A taste of Chinese New Year in Guangdong: top picks from Consuls General in Guangzhou
GUANGZHOU, China, Feb. 20, 2026 /PRNewswire/ -- A news report from South:…
New Guidelines from NCCN Detail Fundamental Differences in Cancer in Children Compared to Adults
National Comprehensive Cancer Network publishes new guidelines for Pediatric Soft Tissue Sarcomas,…
Datatonic Addresses Productivity Leakage to Move AI From Efficiency to Impact
Datatonic addresses "productivity leakage" as the primary driver of value erosion in…
From Blueprint to Blue Water: India’s Indigenous Giants to Command Global Spotlight During Maritime Convergence 2026
VISAKHAPATNAM, India, Feb. 17, 2026 /PRNewswire/ -- The Indian Navy's simultaneous deployment…
From Farm to Future: Avid Learning Leads Conversation on Climate and Food Security Ahead of Mumbai Climate Week 2026
MUMBAI, India, Feb. 16, 2026 /PRNewswire/ -- As series of spoke events kick…
Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470
Press Release Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA…
Upstream Bio Reports Positive Top-line Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma
February 11, 2026 06:00 ET | Source: Upstream Bio – Verekitug provided…
